A compound that selectively binds to the messenger RNA that encodes alpha-synuclein protein inhibits its translation in cells and could slow progression of Parkinson's disease, researchers reported in Proceedings of the National Academy of Sciences. The researchers used an RNA/protein-matching technology to identify the compound, and study co-author Maral Mouradian says the method could be applied to other neurodegenerative diseases.
Targeting mRNA could prevent Parkinson's progression
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.